CME credits: 0.25 Valid until: 14-12-2025 Claim your CME credit at https://reachmd.com/programs/cme/advanced-therapeutic-strategies-and-resistance-mechanisms-in-cll/36332/ Listen to Dr. Shankara Paneesha and discover the evolving treatment landscape for relapsed CLL. Get insights on BTK resistance, new treatment options including cellular therapy, and the importance of patient-specific factors in treatment decisions.=

Host: Marshall Miller Step into 17th-century London, where the medical field was less science and more superstition. In this episode of Rub Some Dirt in It, Marshall Miller dives into the quirky and sometimes downright absurd causes of death listed in 1632. From “King’s Evil,” supposedly cured by royal touch, to “Cut of the Stone” surgery without anesthesia, history shows just how far medicine has come.

Host: Marshall Miller Step into 17th-century London, where the medical field was less science and more superstition. In this episode of Rub Some Dirt in It, Marshall Miller dives into the quirky and sometimes downright absurd causes of death listed in 1632. From “King’s Evil,” supposedly cured by royal touch, to “Cut of the Stone” surgery without anesthesia, history shows just how far medicine has come.

Host: Charles Turck, PharmD, BCPS, BCCCP Guest: Forat Lutfi, MD Guest: Nilanjan Ghosh, MD, PhD For patients with relapsed/refractory large B-cell lymphoma, timely access to CAR T-cell therapy can be life-saving, but communication gaps between referring physicians and CAR T centers can lead to delays or missed opportunities. Fortunately, practical strategies like building strong referral networks, improving direct communication, and aligning on shared care responsibilities can

Guest: Aasma Shaukat, MD, MPH As fecal immunochemical testing (FIT) becomes more common in colorectal cancer screening, questions remain about post-FIT follow-up, especially when colonoscopies yield negative results. To explore this further, a recent review looked at the risk of colorectal cancer postcolonoscopy and analyzed the most common reasons it may occur. Hear Dr. Aasma Shaukat, a coauthor of the review, discuss the rationale behind it and its findings, which highlighted the

Guest: Aasma Shaukat, MD, MPH Despite available options like stool-based testing and colonoscopy, colorectal cancer screening rates remain low. Blood-based testing, however, has the potential to improve adherence by offering a convenient alternative. Join Dr. Aasma Shaukat as she discusses the clinical performance of blood-based testing, its limitations, and its role in real-world settings. Dr. Shaukat is the Robert M. and Mary H. Glickman Professor of Medicine and a Professor in the

In this podcast, Elizabeth Asige & Gillian Saloojee discuss their paper 'Impact of the Akwenda Intervention Program for cerebral palsy on caregiver-perceived burden, stress, and psychosocial functioning: A cluster-randomized trial in Uganda'.The paper is available here: https://doi.org/10.1111/dmcn.16406 Follow DMCN on Podbean for more: https://dmcn.podbean.com/ ___ Watch DMCN Podcasts on YouTube: https://bit.ly/2ONCYiC __ DMCN Journal: Developmental Medicine & Child Neurology (DMCN)

Eye On The Night Sky For Wednesday, August 20

Humanist Strategies for Early Educators: Nurturing Growth with Compassion and Reason

Fibrodysplasia ossificans progressiva (FOP) is a severely disabling myopathy in which extraskeletal bone forms and accumulates over time within muscles and soft tissues.1,2 Here’s what we know so far about the mechanisms of heterotopic ossification in patients with FOP. References: Kaplan FS et al. Best Pract Res Clin Rheumatol 2008;22:191–205. Pignolo RJ et al. Orphanet J Rare Dis 2011;6:80. © 2025 Ipsen Biopharmaceuticals Inc. All rights reserved. ALLSC-US-001927 | August 2025

Early symptoms of multiple sclerosis (MS) often present as clear, localized neurological changes lasting several days. However, many nonspecific complaints and common MRI findings can mimic MS, leading to misdiagnosis and unnecessary treatment. Dr. Jonathan Howard, an Associate Professor of Neurology and Psychiatry at the NYU Grossman School of Medicine and the Director of the Neurology Service at Bellevue Hospital, reviews hallmark symptom patterns, explains how to differentiate benign

Since 2010, the landscape of multiple sclerosis care has transformed to encompass a variety of medications, each having unique benefits, risks, and side effect profiles. Dr. Jonathan Howard discusses how to match treatment strength to disease severity and balance patient risk tolerance with evolving therapeutic options, from long-standing injectables to infusions and oral therapies. Dr. Howard is an Associate Professor of Neurology and Psychiatry at the NYU Grossman School of Medicine and

Host: Jennifer Caudle, DO Guest: Johanna Finkle, MD, FACOG As GLP-1 therapies grow in popularity for weight management and diabetes, an unexpected consequence has emerged: a rise in unplanned pregnancies due to reduced oral contraceptive effectiveness. Dr. Jennifer Caudle sits down with Dr. Johanna Finkle, a weight loss specialist and OB/GYN at the University of Kansas Health System, to explore the mechanisms behind this trend and outline practical, long-acting contraceptive

Show 22 - Protected Forever - One key thing that the landowners I’ve interviewed so far on Rewilding in action have in common is an open space QEII covenant on their land. Join me, Maureen Howard as I chat with my guest Dr Cathy Rufaut, a Regional Representative from QEII. Find out what this type of covenant is and the options out there, the benefits of a QEII covenant over other covenant types and what QEII is able to provide in the current economic climate. This episode of Rewilding in Action is

Coastal wetlands are among the most productive ecosystems on our planet. They are a boon for plants, animals, and people alike. However, sea level rise is changing these ecosystems and the communities that rely on them. Join me and Dr. Keryn Gedan as we explore the links between sea level rise, wetland migration, and ghost forests and learn how communities are bracing themselves for adapting to these changes. This episode was produced in part by Nadia, Heidi, Blake, Josh, Laure, R.J., Carly, Lucia,

Show notes at pharmacyjoe.com/episode1052. In this episode, I’ll discuss the most effective and safest therapies for nausea/emesis in adult patients presenting to the emergency department (ED).The post 1052: The Best and the Worst Antiemetics in the ED appeared first on Pharmacy Joe.

Emitido el 21 de agosto de 2025, puede descargarlo desde aquí: - Universo cataclísmico, materia oscura y los misterios de la gravedad.O escucharlo aquí:Tratamos los siguientes temas:- Universo cataclísmico, materia oscura y los misterios de la gravedad.- Una astrónoma que sentó las bases para establecer la inmensidad del cosmos.- 3I/ATLAS: un recién llegado interestelar.- Los casquetes polares de Groenlandia y el verdadero alcance del cambio climático.En Spotify:

In the rapidly evolving landscape of drug discovery, the ability to integrate high-quality research findings into knowledge graphs is paramount. For over twenty years, our scientists have curated the relationships between genes, drugs, diseases, and pathways to power Ingenuity Pathway Analysis. Now, these data are available via our QIAGEN Biomedical KB-HD, which provides direct access to flat files, SQL APIs in Python and R, and the ability to export knowledge graph objects for analysis in Neo4j. In

Since the completion of the Human Genome Project over two decades ago, genomics has become progressively entrenched within the bedrock of the biomedical research enterprise. Capitalizing on the momentum of the project’s successful completion, the field of genomics has increasingly expanded and matured, such that genomics is now central and catalytic in basic and translational research, and studies now regularly demonstrate the vital role that genomic information can play in clinical care.Looking

Over two decades of research have uncovered over 100 genes with rare mutations linked to autism spectrum disorder (ASD), yet transcriptomic and epigenetic analyses reveal convergent dysregulation patterns in ASD brain tissue. In this webinar, learn how Dr. Dan Geschwind and his team at UCLA combine bioinformatics and experimental approaches to show that both common and rare genetic variations converge during early fetal cortical development. Using the largest hiPSC patient cohort and cortical